Skip to main content
. 2019 Mar 21;137(5):543–550. doi: 10.1001/jamaophthalmol.2019.0292

Table 1. Baseline Characteristics of Participants.

Characteristics Participants, No. (%)
Total 4751
Age, mean (SD), y 69.4 (5.1)
Sex
Male 2096 (44.1)
Female 2655 (55.9)
Race/ethnicity
White, non-Hispanic 4543 (95.6)
Black, non-Hispanic 177 (3.7)
Hispanic 13 (0.3)
Asian or Pacific Islander 8 (0.2)
Other 10 (0.2)
Educational attainment
≤High school 1708 (36.0)
Some college 1409 (29.7)
College graduate 1634 (34.4)
Smoking status
Never 2105 (44.3)
Former 2271 (47.8)
Current 375 (7.9)
BMI
≤25.0 1550 (32.6)
>25.0 and ≤30 1984 (41.8)
>30.0 1217 (25.6)
Diabetes mellitus
Yes 398 (8.4)
No 4353 (91.6)
Age-Related Eye Disease Study treatment assignment
Placebo 1480 (31.2)
Antioxidants 1481 (31.2)
Zinc 902 (19.0)
Antioxidants plus zinc 888 (18.7)
Antacid use
Absent 3962 (83.4)
Present 789 (16.6)
Nonsteroidal anti-inflammatory drug use
Absent 3211 (67.6)
Present 1540 (32.4)
Calcium use
No 4064 (85.5)
Yes 687 (14.5)
Supplementary calcium-intake tertilesa
No calcium use 4064 (85.5)
1 (Lowest) 277 (5.8)
2 133 (2.8)
3 (Highest) 277 (5.8)
Dietary calcium-intake quintilesa
Missing 6 (0.1)
1 (Lowest) 949 (20.0)
2 950 (20.0)
3 949 (20.0)
4 949 (20.0)
5 (Highest) 948 (20.0)

Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared).

a

Numbers in each quintile and tertile include all Age-Related Eye Disease Study participants (N = 4751), and they differ in size from the calorie restriction–defined groups included in disease outcome statistics.